Skip to main content
SpringerLink
Log in

Role and Regulation of Proteases in Human Glioma

  • Chapter
Proteases In The Brain

Part of the book series: Proteases In Biology and Disease ((PBAD,volume 3))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  • Adachi Y, Lakka SS, Chandrasekar N, Yanamandra N, Gondi CS, Mohanam S, Dinh DH, Olivero WC, Gujrati M, Tamiya T, Ohmoto T, Kouraklis G, Aggarwal B, Rao JS, 2001, Down-regulation of integrin alpha(v)beta(3) expression and integrin-mediated signaling in glioma cells by adenovirus-mediated transfer of antisense urokinase-type plasminogen activator receptor (uPAR) and sense p16 genes. J Biol Chem 276: 47171–47177.

    CAS  PubMed  Google Scholar 

  • Andreasen PA, Kjoller L, Christensen L, Duffy MJ, 1997, The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 72: 1–22.

    Article  CAS  PubMed  Google Scholar 

  • Apodaca G, Rutka JT, Bouhana K, Berens ME, Giblin JR, Rosenblum ML, McKerrow JH, Banda MJ, 1990, Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells. Cancer Res 50: 2322–2329.

    CAS  PubMed  Google Scholar 

  • Arai Y, Kubota T, Nakagawa T, Kabuto M, Sato K, Kobayashi H, 1998, Production of urokinase-type plasminogen activator (u-PA) and plasminogen activator inhibitor-1 (PAI-1) in human brain tumours. Acta Neurochir (Wien) 140: 377–385.

    Article  CAS  Google Scholar 

  • Behrendt N, Ronne E, Dano K, 1993, Binding of the urokinase-type plasminogen activator to its cell surface receptor is inhibited by low doses of suramin. J Biol Chem 268: 5985–5989.

    CAS  PubMed  Google Scholar 

  • Bello L, Giussani C, Carrabba G, Pluderi M, Lucini V, Pannacci M, Caronzolo D, Tomei G, Villani R, Scaglione F, Carroll RS, Bikfalvi A, 2002, Suppression of malignant glioma recurrence in a newly developed animal model by endogenous inhibitors. Clin Cancer Res 8: 3539–3548.

    CAS  PubMed  Google Scholar 

  • Bjerkvig R, Laerum OD, Mella O, 1986, Glioma cell interactions with fetal rat brain aggregates in vitro and with brain tissue in vivo. Cancer Res 46: 4071–4079.

    CAS  PubMed  Google Scholar 

  • Blasi F, Carmeliet P, 2002, uPAR: a versatile signalling orchestrator. Nat Rev Mol Cell Biol 3: 932–943.

    Article  CAS  PubMed  Google Scholar 

  • Bodey B, Bodey B Jr, Siegel SE, Kaiser HE, 2000a, Matrix metalloproteinase expression in childhood astrocytomas. Anticancer Res 20: 3287–3292.

    CAS  PubMed  Google Scholar 

  • Bodey B, Bodey B Jr, Siegel SE, Kaiser HE, 2000b, Matrix metalloproteinase expression in childhood medulloblastomas/primitive neuroectodermal tumors. In Vivo 14: 667–673.

    CAS  PubMed  Google Scholar 

  • Bu X, Khankaldyyan V, Gonzales-Gomez I, Groshen S, Ye W, Zhuo S, Pons J, Stratton JR, Rosenberg S, Laug WE, 2004, Species-specific urokinase receptor ligands reduce glioma growth and increase survival primarily by an antiangiogenesis mechanism. Lab Invest 84: 667–678.

    Article  CAS  PubMed  Google Scholar 

  • Cal S, Obaya AJ, Llamazares M, Garabaya C, Quesada V, Lopez-Otin C, 2002, Cloning, expression analysis, and structural characterization of seven novel human ADAMTSs, a family of metalloproteinases with disintegrin and thrombospondin-1 domains. Gene 283: 49–62.

    Article  CAS  PubMed  Google Scholar 

  • Calkins CC, Sloane BF, 1995, Mammalian cysteine protease inhibitors: biochemical properties and possible roles in tumor progression. Biological Chemistry Hoppe-Seyler 376: 71–80.

    CAS  PubMed  Google Scholar 

  • Castino R, Pace D, Demoz M, Gargiulo M, Ariatta C, Raiteri E, Isidore C, 2002, Lysosomal proteases as potential targets for the induction of apoptotic cell death in human neuroblastomas. Int J Cancer 97: 775–779.

    Article  CAS  PubMed  Google Scholar 

  • Chandrasekar N, Mohanam S, Gujrati M, Olivero WC, Dinh DH, Rao JS, 2003, Downregulation of uPA inhibits migration and PI3k/Akt signaling in glioblastoma cells. Oncogene 22: 392–400.

    Article  CAS  PubMed  Google Scholar 

  • Chintala SK, Kyritsis AP, Mohan PM, Mohanam S, Sawaya R, Gokslan Z, Yung WK, Steck P, Uhm JH, Aggarwal BB, Rao JS, 1999, Altered actin cytoskeleton and inhibition of matrix metalloproteinase expression by vanadate and phenylarsine oxide, inhibitors of phosphotyrosine phosphatases: modulation of migration and invasion of human malignant glioma cells. Molecular Carcinogenesis 26: 274–285.

    Article  CAS  PubMed  Google Scholar 

  • Chintala SK, Mohanam S, Go Y, Venkaiah B, Sawaya R, Gokaslan ZL, Rao JS, 1997, Altered in vitro spreading and cytoskeletal organization in human glioma cells by downregulation of urokinase receptor. Molecular Carcinogenesis 20: 355–365.

    Article  CAS  PubMed  Google Scholar 

  • Chintala SK, Sawaya R, Aggarwal BB, Majumder S, Giri DK, Kyritsis AP, Gokaslan ZL, Rao JS, 1998, Induction of matrix metalloproteinase-9 requires a polymerized actin cytoskeleton in human malignant glioma cells. J Biol Chem 273: 13545–13551.

    Article  CAS  PubMed  Google Scholar 

  • Chintala SK, Sawaya R, Gokaslan ZL, Rao JS, 1996, Modulation of matrix metalloprotease-2 and invasion in human glioma cells by alpha 3 beta 1 integrin. Cancer Lett 103: 201–208.

    Article  CAS  PubMed  Google Scholar 

  • Choe G, Park JK, Jouben-Steele L, Kremen TJ, Liau LM, Vinters HV, Cloughesy TF, Mischel PS, 2002, Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype. Clin Cancer Res 8: 2894–2901.

    CAS  PubMed  Google Scholar 

  • d’Ortho MP, Will H, Atkinson S, Butler G, Messent A, Gavrilovic J, Smith B, Timpl R, Zardi L, Murphy G, 1997, Membrane-type matrix metalloproteinases 1 and 2 exhibit broadspectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur J Biochem 250: 751–757.

    CAS  PubMed  Google Scholar 

  • da Rocha AB, Mans DR, Lenz G, Fernandes AK, de Lima C, Monteiro VF, Goncalves D, Moreira JC, Brunetto AL, Rodnight R, Schwartsmann G, 2000, Protein kinase C-mediated in vitro invasion of human glioma cells through extracellular-signal-regulated kinase and ornithine decarboxylase. Pathobiology 68: 113–123.

    PubMed  Google Scholar 

  • Dano K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, Skriver L, 1985, Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 44: 139–266.

    CAS  PubMed  Google Scholar 

  • Deb S, Zhang JW, Gottschall PE, 1999, Activated isoforms of MMP-2 are induced in U87 human glioma cells in response to beta-amyloid peptide. J Neurosci Res 55: 44–53.

    Article  CAS  PubMed  Google Scholar 

  • Demchik LL, Sameni M, Nelson K, Mikkelsen T, Sloane BF, 1999, Cathepsin B and glioma invasion. Int J Dev Neurosci 17: 483–494.

    CAS  PubMed  Google Scholar 

  • Deng G, Curriden SA, Wang S, Rosenberg S, Loskutoff DJ, 1996, Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release? J Cell Biol 134: 1563–1571.

    Article  CAS  PubMed  Google Scholar 

  • Deryugina EI, Bourdon MA, Luo GX, Reisfeld RA, Strongin A, 1997, Matrix metalloproteinase-2 activation modulates glioma cell migration. J Cell Sci 110: 2473–2482.

    CAS  PubMed  Google Scholar 

  • Deshane J, Garner CC, Sontheimer H, 2003, Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2. J Biol Chem 278: 4135–4144.

    Article  CAS  PubMed  Google Scholar 

  • Edwards DR, Murphy G, 1998, Cancer. Proteases-invasion and more. Nature 394: 527–528.

    CAS  PubMed  Google Scholar 

  • Egeblad M, Werb Z, 2002, New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2: 161–174.

    Article  CAS  PubMed  Google Scholar 

  • Flannery T, Gibson D, Mirakhur M, McQuaid S, Greenan C, Trimble A, Walker B, McCormick D, Johnston PG, 2003, The clinical significance of cathepsin S expression in human astrocytomas. Am J Pathol 163: 175–182.

    CAS  PubMed  Google Scholar 

  • Forsyth PA, Laing TD, Gibson AW, Rewcastle NB, Brasher P, Sutherland G, Johnston RN, Edwards DR, 1998, High levels of gelatinase-B and active gelatinase-A in metastatic glioblastoma. J Neurooncol 36: 21–29.

    Article  CAS  PubMed  Google Scholar 

  • Forsyth PA, Wong H, Laing TD, Rewcastle NB, Morris DG, Muzik H, Leco KJ, Johnston RN, Brasher PM, Sutherland G, Edwards DR, 1999, Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas. Br J Cancer 79: 1828–1835.

    Article  CAS  PubMed  Google Scholar 

  • Fridman R, Toth M, Pena D, Mobashery S, 1995, Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res 55: 2548–2555.

    CAS  PubMed  Google Scholar 

  • Gibson SB, Oyer R, Spalding AC, Anderson SM, Johnson GL, 2000, Increased expression of death receptors 4 and 5 synergizes the apoptosis response to combined treatment with etoposide and TRAIL. Mol Cell Biol 20: 205–212.

    CAS  PubMed  Google Scholar 

  • Gladson CL, Cheresh DA, 1991, Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells. J Clin Invest 88: 1924–1932.

    CAS  PubMed  Google Scholar 

  • Go Y, Chintala SK, Mohanam S, Gokaslan Z, Venkaiah B, Bjerkvig R, Oka K, Nicolson GL, Sawaya R, Rao JS, 1997, Inhibition of in vivo tumorigenicity and invasiveness of a human glioblastoma cell line transfected with antisense uPAR vectors. Clin Exp Metastasis 15: 440–446.

    CAS  PubMed  Google Scholar 

  • Gondi CS, Lakka SS, Yanamandra N, Siddique K, Dinh DH, Olivero WC, Gujrati M, Rao JS, 2003, Expression of antisense uPAR and antisense uPA from a bicistronic adenoviral construct inhibits glioma cell invasion, tumor growth, and angiogenesis. Oncogene 22: 5967–5975.

    Article  CAS  PubMed  Google Scholar 

  • Gondi CS, Lakka SS, Yanamandra N, Olivero WC, Dinh DH, Gujrati M, Tung CH, Weissleder R, and Rao JS, 2004, Adenovirus-mediated expression of antisense urokinase plasminogen activator receptor and antisense cathepsin B inhibits tumor growth, invasion, and angiogenesis in gliomas. Cancer Res 64: 4069–4077.

    Article  CAS  PubMed  Google Scholar 

  • Gottschall PE, Deb S, 1996, Regulation of matrix metalloproteinase expressions in astrocytes, microglia and neurons. Neuroimmunomodulation. 3: 69–75.

    CAS  PubMed  Google Scholar 

  • Guo Y, Higazi AA, Arakelian A, Sachais BS, Cines D, Goldfarb RH, Jones TR, Kwaan H, Mazar AP, Rabbani SA, 2000, A peptide derived from the nonreceptor binding region of urokinase plasminogen activator (uPA) inhibits tumor progression and angiogenesis and induces tumor cell death in vivo. FASEB J 14: 1400–1410.

    Article  CAS  PubMed  Google Scholar 

  • Hamasuna R, Kataoka H, Moriyama T, Itoh H, Seiki M, Koono M, 1999, Regulation of matrix metalloproteinase-2 (MMP-2) by hepatocyte growth factor/scatter factor (HGF/SF) in human glioma cells: HGF/SF enhances MMP-2 expression and activation accompanying up-regulation of membrane type-1 MMP. Int J Cancer 82: 274–281.

    Article  CAS  PubMed  Google Scholar 

  • Hjortland GO, Bjornland K, Pettersen S, Garman-Vik SS, Emilsen E, Nesland JM, Fodstad O, Engebraaten O, 2003, Modulation of glioma cell invasion and motility by adenoviral gene transfer of PAI-1. Clin Exp Metastasis 20: 301–309.

    Article  CAS  PubMed  Google Scholar 

  • Hotary K, Allen E, Punturieri A, Yana I, Weiss SJ, 2000, Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. J Cell Biol 149: 1309–1323.

    Article  CAS  PubMed  Google Scholar 

  • Hoyer-Hansen G, Behrendt N, Ploug M, Dano K, Preissner KT, 1997, The intact urokinase receptor is required for efficient vitronectin binding: receptor cleavage prevents ligand interaction. FEBS Lett 420: 79–85.

    CAS  PubMed  Google Scholar 

  • Hsu DW, Efird JT, Hedley-Whyte ET, 1995, Prognostic role of urokinase-type plasminogen activator in human gliomas. Am J Pathol 147: 114–123.

    CAS  PubMed  Google Scholar 

  • Hur JH, Park MJ, Park 1C, Yi DH, Rhee CH, Hong SI, Lee SH, 2000, Matrix metalloproteinases in human gliomas: activation of matrix metalloproteinase-2 (MMP-2) may be correlated with membrane-type-1 matrix metalloproteinase (MT1-MMP) expression. J Korean Med Sci 15: 309–314.

    CAS  PubMed  Google Scholar 

  • Isahara K, Ohsawa Y, Kanamori S, Shibata M, Waguri S, Sato N, Gotow T, Watanabe T, Momoi T, Urase K, Kominami E, Uchiyama Y, 1999, Regulation of a novel pathway for cell death by lysosomal aspartic and cysteine proteinases. Neuroscience 91: 233–249.

    Article  CAS  PubMed  Google Scholar 

  • Isogai C, Laug WE, Shimada H, Declerck PJ, Stins MF, Durden DL, Erdreich-Epstein A, DeClerck YA, 2001, Plasminogen activator inhibitor-1 promotes angiogenesis by stimulating endothelial cell migration toward fibronectin. Cancer Res 61: 5587–5594.

    CAS  PubMed  Google Scholar 

  • Itoh T, Tanioka M, Yoshida H, Yoshioka T, Nishimoto H, Itohara S, 1998, Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res 58: 1048–1051.

    CAS  PubMed  Google Scholar 

  • Joyce JA, Baruch A, Chehade K, Meyer-Morse N, Giraudo E, Tsai FY, Greenbaum DC, Hager JH, Bogyo M, Hanahan D, 2004, Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. Cancer Cell 5: 443–453.

    Article  CAS  PubMed  Google Scholar 

  • Kachra Z, Beaulieu E, Delbecchi L, Mousseau N, Berthelet F, Moumdjian R, Del Maestro R, Beliveau R, 1999, Expression of matrix metalloproteinases and their inhibitors in human brain tumors. Clin Exp Metastasis 17: 555–566.

    Article  CAS  PubMed  Google Scholar 

  • Kanse SM, Kost C, Wilhelm OG, Andreasen PA, Preissner KT, 1996, The urokinase receptor is a major vitronectin-binding protein on endothelial cells. Exp Cell Res 224: 344–353.

    Article  CAS  PubMed  Google Scholar 

  • Kin Y, Chintala SK, Go Y, Sawaya R, Mohanam S, Kyritsis AP, Rao JS, 2000, A novel role for the urokinase-type plasminogen activator receptor in apoptosis of malignant gliomas. Int J Oncol 17: 61–65.

    CAS  PubMed  Google Scholar 

  • Kobayashi H, Ohi H, Sugimura M, Shinohara H, Fujii T, Terao T, 1992, Inhibition of in vitro ovarian cancer cell invasion by modulation of urokinase-type plasminogen activator and cathepsin B. Cancer Res 52: 3610–3614.

    CAS  PubMed  Google Scholar 

  • Koblinski JE, Ahram M, Sloane BF, 2000, Unraveling the role of proteases in cancer. Clin Chim Acta 291: 113–135.

    Article  CAS  PubMed  Google Scholar 

  • Kondraganti S, Mohanam S, Chintala SK, Kin Y, Jasti SL, Nirmala C, Lakka SS, Adachi Y, Kyritsis AP, Ali-Osman F, Sawaya R, Fuller GN, Rao JS, 2000, Selective suppression of matrix metalloproteinase-9 in human glioblastoma cells by antisense gene transfer impairs glioblastoma cell invasion. Cancer Res 60: 6851–6855.

    CAS  PubMed  Google Scholar 

  • Konduri S, Lakka SS, Tasiou A, Yanamandra N, Gondi CS, Dinh DH, Olivero WC, Gujrati M, Rao JS, 2001, Elevated levels of cathepsin B in human glioblastoma cell lines. Int J Oncol 19: 519–524.

    CAS  PubMed  Google Scholar 

  • Konduri SD, Yanamandra N, Siddique K, Joseph A, Dinh DH, Olivero WC, Gujrati M, Kouraklis G, Swaroop A, Kyritsis AP, Rao JS, 2002, Modulation of cystatin C expression impairs the invasive and tumorigenic potential of human glioblastoma cells. Oncogene 21: 8705–8712.

    CAS  PubMed  Google Scholar 

  • Kono S, Rao JS, Bruner JM, Sawaya R, 1994, Immunohistochemical localization of plasminogen activator inhibitor type 1 in human brain tumors. J Neuropathol Exp Neurol 53: 256–262.

    CAS  PubMed  Google Scholar 

  • Kruger A, Soeltl R, Lutz V, Wilhelm OG, Magdolen V, Rojo EE, Hantzopoulos PA, Graeff H, Gansbacher B, Schmitt M, 2000, Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87). Cancer Gene Ther 7: 292–299.

    CAS  PubMed  Google Scholar 

  • Lah TT, Strojnik T, Levicar N, Bervar A, Zajc I, Pilkington G, Kos J, 2000, Clinical and experimental studies of cysteine cathepsins and their inhibitors in human brain tumors. Int J Biol Markers 15: 90–93.

    CAS  PubMed  Google Scholar 

  • Lakka SS, Gondi CS, Yanamandra N, Dinh DH, Olivero WC, Gujrati M, Rao JS, 2003, Synergistic down-regulation of urokinase plasminogen activator receptor and matrix metalloproteinase-9 in SNB19 glioblastoma cells efficiently inhibits glioma cell invasion, angiogenesis, and tumor growth. Cancer Res 63: 2454–2461.

    CAS  PubMed  Google Scholar 

  • Lakka SS, Gondi CS, Yanamandra N, Olivero WC, Dinh DH, Gujrati M, Rao JS, 2004, Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis. Oncogene 23: 4681–4689.

    Article  CAS  PubMed  Google Scholar 

  • Lakka SS, Jasti SL, Kyritsis AP, Yung WK, Ali-Osman F, Nicolson GL, Rao JS, 2000, Regulation of MMP-9 (type IV collagenase) production and invasiveness in gliomas by the extracellular signal-regulated kinase and jun amino-terminal kinase signaling cascades. Clin Exp Metastasis 18: 245–252.

    CAS  PubMed  Google Scholar 

  • Lakka SS, Rajan M, Gondi C, Yanamandra N, Chandrasekar N, Jasti SL, Adachi Y, Siddique K, Gujrati M, Olivero W, Dinh DH, Kouraklis G, Kyritsis AP, Rao JS, 2002, Adenovirusmediated expression of antisense MMP-9 in glioma cells inhibits tumor growth and invasion. Oncogene 21: 8011–8019.

    CAS  PubMed  Google Scholar 

  • Lampert K, Machein U, Machein MR, Conca W, Peter HH, Volk B, 1998, Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors. Am J Pathol 153: 429–437.

    CAS  PubMed  Google Scholar 

  • Levicar N, Dewey RA, Daley E, Bates TE, Davies D, Kos J, Pilkington GJ, Lah TT, 2003, Selective suppression of cathepsin L by antisense cDNA impairs human brain tumor cell invasion in vitro and promotes apoptosis. Cancer Gene Ther 10: 141–151.

    CAS  PubMed  Google Scholar 

  • Lignelid H, Collins VP, Jacobsson B, 1997, Cystatin C and transthyretin expression in normal and neoplastic tissues of the human brain and pituitary. Acta Neuropathol (Berl) 93: 494–500.

    CAS  Google Scholar 

  • Llano E, Pendas AM, Freije JP, Nakano A, Knauper V, Murphy G, Lopez-Otin C, 1999, Identification and characterization of human MT5-MMP, a new membrane-bound activator of progelatinase a overexpressed in brain tumors. Cancer Res 59: 2570–2576.

    CAS  PubMed  Google Scholar 

  • Lund-Johansen M, Rucklidge GJ, Milne G, Bjerkvig R, 1991, A metalloproteinase, capable of destroying cultured brain tissue isolated from rat glioma cells. Anticancer Res 11: 1001–1006.

    CAS  PubMed  Google Scholar 

  • Maeda A, Sobel RA, 1996, Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions. J Neuropathol Exp Neural 55: 300–309.

    CAS  Google Scholar 

  • Mandriota SJ, Seghezzi G, Vassalli JD, Ferrara N, Wasi S, Mazzieri R, Mignatti P, Pepper MS, 1995, Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells. J Biol Chem 270: 9709–9716.

    CAS  PubMed  Google Scholar 

  • Matsuzawa K, Fukuyama K, Hubbard SL, Dirks PB, Rutka JT, 1996, Transfection of an invasive human astrocytoma cell line with a TIMP-1 cDNA: modulation of astrocytoma invasive potential. J Neuropathol Exp Neurol 55: 88–96.

    CAS  PubMed  Google Scholar 

  • Mazar AP, Henkin J, Goldfarb RH, 1999, The urokinase plasminogen activator system in cancer: implications for tumor angiogenesis and metastasis. Angiogenesis. 3: 15–32.

    Article  CAS  PubMed  Google Scholar 

  • Mercapide J, Lopez DC, Castresana JS, Klein-Szanto AJ, 2003, Stromelysin-1 /matrix metalloproteinase-3 (MMP-3) expression accounts for invasive properties of human astrocytoma cell lines. Int J Cancer 106: 676–682.

    Article  CAS  PubMed  Google Scholar 

  • Mikkelsen T, Yan PS, Ho KL, Sameni M, Sloane BF, Rosenblum ML, 1995, Immunolocalization of cathepsin B in human glioma: implications for tumor invasion and angiogenesis. J Neurosurg 83: 285–290.

    CAS  PubMed  Google Scholar 

  • Mishima K, Mazar AP, Gown A, Skelly M, Ji XD, Wang XD, Jones TR, Cavenee WK, Huang HJ, 2000, A peptide derived from the non-receptor-binding region of urokinase plasminogen activator inhibits glioblastoma growth and angiogenesis in vivo in combination with cisplatin. Proc Natl Acad Sci USA 97: 8484–8489.

    Article  CAS  PubMed  Google Scholar 

  • Miyake K, Kimura S, Nakanishi M, Hisada A, Hasegawa M, Nagao S, Abe Y, 2000, Transforming growth factor-beta 1 stimulates contraction of human glioblastoma cellmediated collagen lattice through enhanced alpha2 integrin expression. J Neuropathol Exp Neurol 59: 18–28.

    CAS  PubMed  Google Scholar 

  • Mohan PM, Chintala SK, Mohanam S, Gladson CL, Kim ES, Gokaslan ZL, Lakka SS, Roth JA, Fang B, Sawaya R, Kyritsis AP, Rao JS, 1999, Adenovirus-mediated delivery of antisense gene to urokinase-type plasminogen activator receptor suppresses glioma invasion and tumor growth. Cancer Res 59: 3369–3373.

    CAS  PubMed  Google Scholar 

  • Mohanam S, Chandrasekar N, Yanamandra N, Khawar S, Mirza F, Dinh DH, Olivero WC, Rao JS, 2002, Modulation of invasive properties of human glioblastoma cells stably expressing amino-terminal fragment of urokinase-type plasminogen activator. Oncogene 21: 7824–7830.

    Article  CAS  PubMed  Google Scholar 

  • Mohanam S, Gladson CL, Rao CN, Rao JS, 1999, Biological significance of the expression of urokinase-type plasminogen activator receptors (uPARs) in brain tumors. Frontiers in Bioscience 4: D178–D187.

    CAS  PubMed  Google Scholar 

  • Mohanam S, Jasti SL, Kondraganti SR, Chandrasekar N, Lakka SS, Kin Y, Fuller GN, Yung AW, Kyritsis AP, Dinh DH, Olivero WC, Gujrati M, Ali-Osman F, Rao JS, 2001, Downregulation of cathepsin B expression impairs the invasive and tumorigenic potential of human glioblastoma cells. Oncogene 20: 3665–3673.

    Article  CAS  PubMed  Google Scholar 

  • Mohanam S, Wang SW, Rayford A, Yamamoto M, Sawaya R, Nakajima M, Liotta LA, Nicolson GL, Stetler-Stevenson WG, Rao JS, 1995, Expression of tissue inhibitors of metalloproteinases: negative regulators of human glioblastoma invasion in vivo. Clin Exp Metastasis 13: 57–62.

    Article  CAS  PubMed  Google Scholar 

  • Mori T, Abe T, Wakabayashi Y, Hikawa T, Matsuo K, Yamada Y, Kuwano M, Hori S, 2000, Up-regulation of urokinase-type plasminogen activator and its receptor correlates with enhanced invasion activity of human glioma cells mediated by transforming growth factor-alpha or basic fibroblast growth factor. J Neurooncol 46: 115–123.

    Article  CAS  PubMed  Google Scholar 

  • Muir EM, Adcock KH, Morgenstern DA, Clayton R, von Stillfried N, Rhodes K, Ellis C, Fawcett JW, Rogers JH, 2002, Matrix metalloproteases and their inhibitors are produced by overlapping populations of activated astrocytes. rain Res Mol Brain Res 100: 103–117.

    CAS  Google Scholar 

  • Muracciole X, Romain S, Dufour H, Palmari J, Chinot O, Ouafik L, Grisoli F, Branger DF, Martin PM, 2002, PAI-1 and EGFR expression in adult glioma tumors: toward a molecular prognostic classification. Int J Radiat Oncol Biol Phys 52: 592–598.

    Article  CAS  PubMed  Google Scholar 

  • Murphy G, Knauper V, Cowell S, Hembry R, Stanton H, Butler G, Freije J, Pendas AM, Lopez-Otin C, 1999, Evaluation of some newer matrix metalloproteinases. Ann N Y Acad Sci 878: 25–39.

    CAS  PubMed  Google Scholar 

  • Naito K, Kanbayashi N, Nakajima S, Murai T, Arakawa K, Nishimura S, Okuyama A, 1994, Inhibition of growth of human tumor cells in nude mice by a metalloproteinase inhibitor. Int J Cancer 58: 730–735.

    CAS  PubMed  Google Scholar 

  • Nakada M, Miyamori H, Yamashita J, Sato H, 2003, Testican 2 abrogates inhibition of membrane-type matrix metalloproteinases by other testican family proteins. Cancer Res 63: 3364–3369.

    CAS  PubMed  Google Scholar 

  • Nakada M, Nakamura H, Ikeda E, Fujimoto N, Yamashita J, Sato H, Seiki M, Okada Y, 1999, Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors. Am J Pathol 154: 417–428.

    CAS  PubMed  Google Scholar 

  • Nakagawa T, Kubota T, Kabuto M, Fujimoto N, Okada Y, 1996, Secretion of matrix metalloproteinase-2 (72 kD gelatinase/type IV collagenase = gelatinase A) by malignant human glioma cell lines: implications for the growth and cellular invasion of the extracellular matrix. J Neurooncol 28: 13–24.

    Article  CAS  PubMed  Google Scholar 

  • Nakagawa T, Kubota T, Kabuto M, Sato K, Kawano H, Hayakawa T, Okada Y, 1994, Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. J Neurosurg 81: 69–77.

    CAS  PubMed  Google Scholar 

  • Nakano A, Tani E, Miyazaki K, Furuyama J, Matsumoto T, 1993, Expressions of matrilysin and stromelysin in human glioma cells. Biochem Biophys Res Commun 192: 999–1003.

    Article  CAS  PubMed  Google Scholar 

  • Nakano A, Tani E, Miyazaki K, Yamamoto Y, Furuyama J, 1995, Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. J Neurosurg 83: 298–307.

    CAS  PubMed  Google Scholar 

  • Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y, 1997, Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 272: 2446–2451.

    CAS  PubMed  Google Scholar 

  • Pagenstecher A, Stalder AK, Campbell IL, 1997, RNAse protection assays for the simultaneous and semiquantitative analysis of multiple murine matrix metalloproteinase (MMP) and MMP inhibitor mRNAs. J Immunol. Methods 206: 1–9.

    Article  CAS  PubMed  Google Scholar 

  • Park JE, Keller GA, Ferrara N, 1993, The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol Biol Cell 4: 1317–1326.

    CAS  PubMed  Google Scholar 

  • Park MJ, Kim MS, Park IC, Kang HS, Yoo H, Park SH, Rhee CH, Hong SI, Lee SH, 2002, PTEN suppresses hyaluronic acid-induced matrix metalloproteinase-9 expression in U87MG glioblastoma cells through focal adhesion kinase dephosphorylation. Cancer Res 62: 6318–6322.

    CAS  PubMed  Google Scholar 

  • Park MJ, Park IC, Hur JH, Rhee CH, Choe TB, Yi DH, Hong SI, Lee SH, 2000, Protein kinase C activation by phorbol ester increases in vitro invasion through regulation of matrix metalloproteinases/tissue inhibitors of metalloproteinases system in D54 human glioblastoma cells. Neurosci Lett 290: 201–204.

    CAS  PubMed  Google Scholar 

  • Paulus W, Tonn JC, 1994, Basement membrane invasion of glioma cells mediated by integrin receptors. J Neurosurg 80: 515–519.

    CAS  PubMed  Google Scholar 

  • Pepper MS, Matsumoto K, Nakamura T, Orci L, Montesano R, 1992, Hepatocyte growth factor increases urokinase-type plasminogen activator (u-PA) and u-PA receptor expression in Madin-Darby canine kidney epithelial cells. J Biol Chem 267: 20493–20496.

    CAS  PubMed  Google Scholar 

  • Pepper MS, Sappino AP, Stocklin R, Montesano R, Orci L, Vassalli JD, 1993, Upregulation of urokinase receptor expression on migrating endothelial cells. J Cell Biol 122: 673–684.

    Article  CAS  PubMed  Google Scholar 

  • Peschon JJ, Slack JL, Reddy P, Stocking KL, Sunnarborg SW, Lee DC, Russell WE, Castner BJ, Johnson RS, Fitzner JN, Boyce RW, Nelson N, Kozlosky CJ, Wolfson MF, Rauch CT, Cerretti DP, Paxton RJ, March CJ, Black RA, 1998, An essential role for ectodomain shedding in mammalian development. Science 282: 1281–1284.

    Article  CAS  PubMed  Google Scholar 

  • Flatten M, Wick W, Wild-Bode C, Aulwurm S, Dichgans J, Weller M, 2000, Transforming growth factors beta(1) (TGF-beta(1)) and TGF-beta(2) promote glioma cell migration via Up-regulation of alpha(V)beta(3) integrin expression. Biochem Biophys Res Commun 268: 607–611.

    Google Scholar 

  • Premzl A, Zavasnik-Bergant V, Turk V, Kos J, 2003, Intracellular and extracellular cathepsin B facilitate invasion of MCF-10A neoT cells through reconstituted extracellular matrix in vitro. Exp Cell Res 283: 206–214.

    Article  CAS  PubMed  Google Scholar 

  • Primakoff P, Myles DG, 2000, The ADAM gene family: surface proteins with adhesion and protease activity. Trends Genet 16: 83–87.

    Article  CAS  PubMed  Google Scholar 

  • Qin H, Moellinger JD, Wells A, Windsor LJ, Sun Y, Benveniste EN, 1998, Transcriptional suppression of matrix metalloproteinase-2 gene expression in human astroglioma cells by TNF-alpha and IFN-gamma. J Immunol. 161: 6664–6673.

    CAS  PubMed  Google Scholar 

  • Qin H, Sun Y, Benveniste EN, 1999, The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells. JBiolChem 274: 29130–29137.

    CAS  Google Scholar 

  • Quaranta V, 2000, Cell migration through extracellular matrix: membrane-type metalloproteinases make the way. J Cell Biol 149: 1167–1170.

    Article  CAS  PubMed  Google Scholar 

  • Raithatha SA, Muzik H, Muzik H, Rewcastle NB, Johnston RN, Edwards DR, Forsyth PA, 2000, Localization of gelatinase-A and gelatinase-B mRNA and protein in human gliomas. Neurooncol 2: 145–150.

    CAS  Google Scholar 

  • Rao JS, Steck PA, Mohanam S, Stetler-Stevenson WG, Liotta LA, Sawaya R, 1993, Elevated levels of M(r) 92,000 type IV collagenase in human brain tumors. Cancer Res 53: 2208–2211.

    CAS  PubMed  Google Scholar 

  • Rao JS, Yamamoto M, Mohaman S, Gokaslan ZL, Fuller GN, Stetler-Stevenson WG, Rao VH, Liotta LA, Nicolson GL, Sawaya RE, 1996, Expression and localization of 92 kDa type IV collagenase/gelatinase B (MMP-9) in human gliomas. Clin Exp Metastasis 14: 12–18.

    CAS  PubMed  Google Scholar 

  • Rao NK, Shi GP, Chapman HA, 1995, Urokinase receptor is a multifunctional protein: influence of receptor occupancy on macrophage gene expression. J Clin Invest 96: 465–474.

    CAS  PubMed  Google Scholar 

  • Rempel SA, Rosenblum ML, Mikkelsen T, Yan PS, Ellis KD, Golembieski WA, Sameni M, Rozhin J, Ziegler G, Sloane BF, 1994, Cathepsin B expression and localization in glioma progression and invasion. Cancer Res 54: 6027–6031.

    CAS  PubMed  Google Scholar 

  • Resnati M, Pallavicini I, Wang JM, Oppenheim J, Serhan CN, Romano M, Blasi F, 2002, The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R. Proc Natl Acad Sci USA 99: 1359–1364.

    Article  CAS  PubMed  Google Scholar 

  • Ribatti D, Leali D, Vacca A, Giuliani R, Gualandris A, Roncali L, Nolli ML, Presta M, 1999, In vivo angiogenic activity of urokinase: role of endogenous fibroblast growth factor-2. J Cell Sci 112 ( Pt 23): 4213–4221.

    PubMed  Google Scholar 

  • Romanic AM, Madri JA, 1994, Extracellular matrix-degrading proteinases in the nervous system. Brain Pathol 4: 145–156.

    CAS  PubMed  Google Scholar 

  • Rooprai HK, McCormick D, 1997, Proteases and their inhibitors in human brain tumours: a review. Anticancer Res 17: 4151–4162.

    CAS  PubMed  Google Scholar 

  • Rooprai HK, Rucklidge GJ, Panou C, Pilkington GJ, 2000, The effects of exogenous growth factors on matrix metalloproteinase secretion by human brain tumour cells. Br J Cancer 82: 52–55.

    Article  CAS  PubMed  Google Scholar 

  • Roshy S, Sloane BF, Moin K, 2003, Pericellular cathepsin B and malignant progression. Cancer Metastasis Rev 22: 271–286.

    Article  CAS  PubMed  Google Scholar 

  • Rucklidge GJ, Lund-Johansen M, Milne G, Bjerkvig R, 1990, Isolation and characterization of a metalloproteinase secreted by rat glioma cells in serum-free culture. Biochem Biophys Res Commun 172: 544–550.

    Article  CAS  PubMed  Google Scholar 

  • Rustamzadeh E, Li C, Doumbia S, Hall WA, Vallera DA, 2003, Targeting the over-expressed urokinase-type plasminogen activator receptor on glioblastoma multiforme. J Neurooncol 65: 63–75.

    Article  PubMed  Google Scholar 

  • Sameshima T, Nabeshima K, Toole BP, Yokogami K, Okada Y, Goya T, Koono M, Wakisaka S, 2000, Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN) (CD147) stimulates production of membrane-type matrix metalloproteinases and activated gelatinase A in co-cultures with brain-derived fibroblasts. Cancer Lett 157: 177–184.

    Article  CAS  PubMed  Google Scholar 

  • Satoh K, Suzuki N, Yokota H, 2000, ADAMTS-4 (a disintegrin and metalloproteinase with thrombospondin motifs) is transcriptionally induced in beta-amyloid treated rat astrocytes. Neurosci Lett 289: 177–180.

    Article  CAS  PubMed  Google Scholar 

  • Sawaya R, Go Y, Kyritisis AP, Uhm J, Venkaiah B, Mohanam S, Gokaslan ZL, Rao JS, 1998, Elevated levels of Mr 92,000 type IV collagenase during tumor growth in vivo. Biochem Biophys Res Commun 251: 632–636.

    Article  CAS  PubMed  Google Scholar 

  • Sawaya RE, Yamamoto M, Gokaslan ZL, Wang SW, Mohanam S, Fuller GN, McCutcheon IE, Stetler-Stevenson WG, Nicolson GL, Rao JS, 1996, Expression and localization of 72 kDa type IV collagenase (MMP-2) in human malignant gliomas in vivo. Clin Exp Metastasis 14: 35–42.

    CAS  PubMed  Google Scholar 

  • Shapiro SD, Fliszar CJ, Broekelmann TJ, Mecham RP, Senior RM, Welgus HG, 1995, Activation of the 92-kDa gelatinase by stromelysin and 4-aminophenylmercuric acetate. Differential processing and stabilization of the carboxyl-terminal domain by tissue inhibitor of metalloproteinases (TIMP). J Biol Chem 270: 6351–6356.

    CAS  PubMed  Google Scholar 

  • Shibata M, Kanamori S, Isahara K, Ohsawa Y, Konishi A, Kametaka S, Watanabe T, Ebisu S, Ishido K, Kominami E, Uchiyama Y, 1998, Participation of cathepsins B and D in apoptosis of PC12 cells following serum deprivation. Biochem Biophys Res Commun 251: 199–203.

    Article  CAS  PubMed  Google Scholar 

  • Shofuda K, Moriyama K, Nishihashi A, Higashi S, Mizushima H, Yasumitsu H, Miki K, Sato H, Seiki M, Miyazaki K, 1998, Role of tissue inhibitor of metalloproteinases-2 (TIMP-2) in regulation of pro-gelatinase A activation catalyzed by membrane-type matrix metalloproteinase-1 (MT1-MMP) in human cancer cells. J Biochem (Tokyo) 124: 462–470.

    CAS  Google Scholar 

  • Sivaparvathi M, McCutcheon I, Sawaya R, Nicolson GL, Rao JS, 1996a, Expression of cysteine protease inhibitors in human gliomas and meningiomas. Clin Exp Metastasis 14: 344–350.

    Article  CAS  PubMed  Google Scholar 

  • Sivaparvathi M, Sawaya R, Gokaslan ZL, Chintala SK, Rao JS, Chintala KS, 1996b, Expression and the role of cathepsin H in human glioma progression and invasion. Cancer Leu 104: 121–126.

    CAS  Google Scholar 

  • Sivaparvathi M, Sawaya R, Wang SW, Rayford A, Yamamoto M, Liotta LA, Nicolson GL, Rao JS, 1995, Overexpression and localization of cathepsin B during the progression of human gliomas. Clin Exp Metastasis 13: 49–56.

    Article  CAS  PubMed  Google Scholar 

  • Sivaparvathi M, Yamamoto M, Nicolson GL, Gokaslan ZL, Fuller GN, Liotta LA, Sawaya R, Rao JS, 1996c, Expression and immunohistochemical localization of cathepsin L during the progression of human gliomas. Clin Exp Metastasis 14: 27–34.

    Article  CAS  PubMed  Google Scholar 

  • Strojnik T, Kos J, Zidanik B, Golouh R, Lah T, 1999, Cathepsin B immunohistochemical staining in tumor and endothelial cells is a new prognostic factor for survival in patients with brain tumors. Clin Cancer Res 5: 559–567.

    CAS  PubMed  Google Scholar 

  • Strojnik T, Zidanik B, Kos J, Lah TT, 2001, Cathepsins B and L are markers for clinically invasive types of meningiomas. Neurosurgery 48: 598–605.

    Article  CAS  PubMed  Google Scholar 

  • Sugiura Y, Ma L, Sun B, Shimada H, Laug WE, Seeger RC, DeClerck YA, 1999, The plastminogen-plasminogen activator (PA) system in neuroblastoma: role of PA inhibitor-1 in metastasis. Cancer Res 59: 1327–1336.

    CAS  PubMed  Google Scholar 

  • Takuma K, Kiriu M, Mori K, Lee E, Enomoto R, Baba A, Matsuda T, 2003, Roles of cathepsins in reperfusion-induced apoptosis in cultured astrocytes. Neurochem Int 42: 153–159.

    Article  CAS  PubMed  Google Scholar 

  • Tang BL, 2001, ADAMTS: a novel family of extracellular matrix proteases. Int J Biochem Cell Biol 33: 33–44.

    Article  CAS  PubMed  Google Scholar 

  • Thorns V, Walter GF, Thorns C, 2003, Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas. Anticancer Res 23: 3937–3944.

    CAS  PubMed  Google Scholar 

  • Tonn JC, Kerkau S, Hanke A, Bouterfa H, Mueller JG, Wagner S, Vince GH, Roosen K, 1999, Effect of synthetic matrix-metalloproteinase inhibitors on invasive capacity and proliferation of human malignant gliomas in vitro. Int J Cancer 80: 764–772.

    Article  CAS  PubMed  Google Scholar 

  • Tressler RJ, Pitot PA, Stratton JR, Forrest LD, Zhuo S, Drummond RJ, Fong S, Doyle MV, Doyle LV, Min HY, Rosenberg S, 1999, Urokinase receptor antagonists: discovery and application to in vivo models of tumor growth. APMIS 107: 168–173.

    CAS  PubMed  Google Scholar 

  • Turk V, Kos J, Turk B, 2004, Cysteine cathepsins (proteases)—on the main stage of cancer? Cancer Cell 5: 409–410.

    Article  CAS  PubMed  Google Scholar 

  • Turk V, Turk B, Turk D, 2001, Lysosomal cysteine proteases: facts and opportunities. EMBO J 20: 4629–4633.

    CAS  PubMed  Google Scholar 

  • Uhm JH, Dooley NP, Oh LY, Yong VW, 1998, Oligodendrocytes utilize a matrix metalloproteinase, MMP-9, to extend processes along an astrocyte extracellular matrix. Glia 22: 53–63.

    Article  CAS  PubMed  Google Scholar 

  • Uhm JH, Dooley NP, Villemure JG, Yong VW, 1996, Glioma invasion in vitro: regulation by matrix metalloprotease-2 and protein kinase C. Clin Exp Metastasis 14: 421–433.

    Article  CAS  PubMed  Google Scholar 

  • Uhm JH, Gladson CL, Rao JS, 1999, The role of integrins in the malignant phenotype of gliomas. Front Biosci. 4: D188–D199.

    CAS  PubMed  Google Scholar 

  • VanMeter TE, Rooprai HK, Kibble MM, Fillmore HL, Broaddus WC, Pilkington GJ, 2001, The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis. J Neurooncol 53: 213–235.

    Article  CAS  PubMed  Google Scholar 

  • Vince GH, Wagner S, Pietsch T, Klein R, Goldbrunner RH, Roosen K, Tonn JC, 1999, Heterogeneous regional expression patterns of matrix metalloproteinases in human malignant gliomas. Int J Dev Neurosci 17: 437–445.

    CAS  PubMed  Google Scholar 

  • von Bredow DC, Cress AE, Howard EW, Bowden GT, Nagle RB, 1998, Activation of gelatinase-tissue-inhibitors-of-metalloproteinase complexes by matrilysin. Biochem J 331 (Pt 3): 965–972.

    Google Scholar 

  • Waltz DA, Chapman HA, 1994, Reversible cellular adhesion to vitronectin linked to urokinase receptor occupancy. J Biol Chem 269: 14746–14750.

    CAS  PubMed  Google Scholar 

  • Waltz DA, Natkin LR, Fujita RM, Wei Y, Chapman HA, 1997, Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin. J Clin Invest 100: 58–67.

    CAS  PubMed  Google Scholar 

  • Werb Z, Vu TH, Rinkenberger JL, Coussens LM, 1999, Matrix-degrading proteases and angiogenesis during development and tumor formation. APMIS 107: 11–18.

    CAS  PubMed  Google Scholar 

  • Westermarck J, Kahari VM, 1999, Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 13: 781–792.

    CAS  PubMed  Google Scholar 

  • Yamamoto M, Ikeda K, Ohshima K, Tsugu H, Kimura H, Tomonaga M, 1998, Expression and cellular localization of low-density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor in human glioblastoma in vivo. Brain Tumor Pathol 15: 23–30.

    CAS  PubMed  Google Scholar 

  • Yamamoto M, Mohanam S, Sawaya R, Fuller GN, Seiki M, Sato H, Gokaslan ZL, Liotta LA, Nicolson GL, Rao JS, 1996, Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Cancer Res 56: 384–392.

    CAS  PubMed  Google Scholar 

  • Yamamoto M, Sawaya R, Mohanam S, Bindal AK, Bruner JM, Oka K, Rao VH, Tomonaga M, Nicolson GL, Rao JS, 1994a, Expression and localization of urokinase-type plasminogen activator in human astrocytomas in vivo. Cancer Res 54: 3656–3661.

    CAS  PubMed  Google Scholar 

  • Yamamoto M, Sawaya R, Mohanam S, Loskutoff DJ, Bruner JM, Rao VH, Oka K, Tomonaga M, Nicolson GL, Rao JS, 1994b, Expression and cellular localization of messenger RNA for plasminogen activator inhibitor type 1 in human astrocytomas in vivo. Cancer Res 54: 3329–3332.

    CAS  PubMed  Google Scholar 

  • Yamamoto M, Sawaya R, Mohanam S, Rao VH, Bruner JM, Nicolson GL, Ohshima K, Rao JS, 1994c, Activities, localizations, and roles of serine proteases and their inhibitors in human brain tumor progression. J Neurooncol 22: 139–151.

    Article  CAS  PubMed  Google Scholar 

  • Yana I, Weiss SJ, 2000, Regulation of membrane type-1 matrix metalloproteinase activation by proprotein convertases. Mol Biol Cell 11: 2387–2401.

    CAS  PubMed  Google Scholar 

  • Yanamandra N, Gumidyala KV, Waldron KG, Gujrati M, Olivero WC, Dinh DH, Rao JS, Mohanam S, 2004, Blockade of cathepsin B expression in human glioblastoma cells is associated with suppression of angiogenesis. Oncogene 23: 2224–2230.

    CAS  PubMed  Google Scholar 

  • Zhu DM, Uckun FM, 2000, Cathepsin inhibition induces apoptotic death in human leukemia and lymphoma cells. Leuk Lymphoma 39: 343–354.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Program of Cancer Biology, University of Illinois, College of Medicine Peoria, One Illini Drive, Peoria, IL, 61605, USA

    Sajani S. Lakka & Jasti S. Rao

Authors
  1. Sajani S. Lakka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jasti S. Rao
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Otto-von-Guericke University, Magdeburg, Germany

    Uwe Lendeckel

  2. University of Leeds, Leeds, UK

    Nigel M. Hooper

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Science + Business Media, Inc. Dordrecht

About this chapter

Cite this chapter

Lakka, S.S., Rao, J.S. (2005). Role and Regulation of Proteases in Human Glioma. In: Lendeckel, U., Hooper, N.M. (eds) Proteases In The Brain. Proteases In Biology and Disease, vol 3. Springer, Boston, MA. https://doi.org/10.1007/0-387-23101-3_7

Download citation

Publish with us

Policies and ethics

Search

Navigation